hVIVO Plc
Phase I results for Imutex's mosquito vaccine candidate published in a leading peer-reviewed journal
By Elric Langton | 19 December 2022
Mike and I have a financial interest in hVIVO.
hVIVO plc (AIM: HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation …